The histopathology services market is projected to reach US$ 35,187.90 million by 2028 from US$ 23,890.44 million in 2021; it is expected to grow at a CAGR of 5.7% from 2021 to 2028.
Histopathology services are used for the microscopic examination of biological tissues in disease diagnosis. With the help of imaging techniques, biopsy tissues can be obtained from certain inaccessible sites, such as pancreas and peritoneum. Factors such as rising demand for biologics and increasing prevalence of chronic diseases are driving the growth of the histopathology services market. However, limitations associated with histopathology and immunohistochemistry are expected to restrict the market growth to a certain extent during the forecast period.
Lucrative Regions for Histopathology Services Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Increasing Prevalence of Chronic Diseases
Chronic diseases such as cardiovascular disorders, neurological disorders, autoimmune disorders, and cancer are the leading cause of death and disability worldwide. As per the Centers for Disease Control and Prevention, in 2019, nearly 6 in 10 people suffered from at least one chronic disease in the US. As per the World Health Organization (WHO), CVDs are the number one cause of death globally, taking an estimated 17.9 million lives each year.
Cancer is one of the leading causes of mortality worldwide, which acts as a huge financial burden on society. According to the WHO, in 2018, ~9.6 million deaths occurred due to cancer globally. However, growing research on developing effective treatments for the disease is influencing the market growth. According to the National Health Profile, the cases of common cancers, including cervical, oral, and breast cancers, have increased by 324% in India from 2017 to 2018. Additionally, the total number of patients visiting Non-Communicable Diseases (NCD) clinics have doubled between 2017 and 2018, which is recorded to be 35 million and 66 million, respectively. Rapid change in lifestyle and consumption of alcohol and tobacco products are among the prominent factors increasing the incidences of cancer among the population.
Autoimmune diseases further contribute to a significant number of populations suffering with various type of diseases. For instance, according to the National Institutes of Health, ~23.5 million Americans suffer from autoimmune diseases, and an additional 8 million people have autoantibodies in blood molecules that indicate a person’s chance of developing autoimmune disease. The underlying cause of various autoimmune diseases is still unknown. Thus, researchers and therapists treating and exploring therapies for these diseases conduct detailed histopathological analysis to understand the mechanism of the diseases and design therapies and treatment for their management. Thus, the rising number of chronic diseases worldwide are expected to account for the growth of the histopathological services market during the forecast period.
Type of Examination -Based Insights
Based on type of examination, the histopathology services market is categorized into surgical specimen, breast biopsy, lung biopsy, renal biopsy, gastrointestinal biopsy, pancreatic biopsy, skin tissue biopsy, testicular biopsy, and others. In 2021, the surgical specimen segment held the largest share of the market and is expected to grow at the fastest rate during the forecast period.
Global Histopathology Services Market, by Type of Examination – 2021 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
End-User-Based Insights
Based on end-user, the histopathology services market has been segmented into diagnostic laboratories and reference laboratories, research institutes, and others. In 2021, the diagnostic laboratories and reference laboratories segment held the largest share of the market and is estimated to grow at a significant CAGR during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Histopathology Services Market: Strategic Insights
Market Size Value in US$ 23,890.44 Million in 2021 Market Size Value by US$ 35,187.90 Million by 2028 Growth rate CAGR of 5.7% from 2021-2028 Forecast Period 2021-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Histopathology Services Market: Strategic Insights
| Market Size Value in | US$ 23,890.44 Million in 2021 |
| Market Size Value by | US$ 35,187.90 Million by 2028 |
| Growth rate | CAGR of 5.7% from 2021-2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Various companies operating in the histopathology services market are adopting strategies such as product launches, mergers and acquisitions, collaborations, product innovations, and product portfolio expansions to expand their footprint worldwide, maintain brand name, and meet the growing demand from end users.
Histopathology Services Market – by Type of Examination
- Surgical Specimen
- Breast Biopsy
- Lung Biopsy
- Renal Biopsy
- Gastrointestinal Biopsy
- Pancreatic Biopsy
- Skin Tissue Biopsy
- Testicular Biopsy
- Others
Histopathology Services Market – by End-User
- Diagnostic Laboratories & Reference Laboratories
- Research Institutes
- Others
Histopathology Services Market – by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
South America (SAM)
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- Sonic Healthcare Limited
- Laboratory Corporation of America Holdings
- Acculabs Diagnostics UK Ltd
- TPL Path Labs
- UNILABS
- Cureline Global Translational CRO
- Targos
- Cellular Pathology Services,
- Experimental Pathology Laboratories Inc (EPL)
- CHARLES RIVER LABORATORIES, INC.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type of Examination ; End User , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Histopathology services are used in the examination of biological tissues for the diagnosis of diseases. The procedure includes microscopic examination of tissues. With the help of imaging techniques biopsy tissues can now be obtained from certain inaccessible sites such as pancreas and the peritoneum.
Key factors that are driving the growth of this market include rising demand for biologics and increasing prevalence of chronic diseases.
Global histopathology services market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for histopathology services. The US is estimated to hold the largest share in the histopathology services market during the forecast period. The growth of the market can be because of prevalence of various diseases, government support for biotechnology and increasing efforts in R&D activities as well as other activities undertaken by the market players operating in the market. In addition, technological advancements in the diagnosis industry is likely to stimulate the growth of histopathology services market in North America. On the other hand, large pool of population suffering with chronic diseases, rapidly developing healthcare infrastructure, and intellectual capabilities of scientists and researchers in the Asia Pacific is expected to account for the fastest growth of the region during the coming years.
The surgical specimen segment dominated the global histopathology services market and held the largest revenue share of 48.51% in 2021.
The diagnostic laboratories and reference laboratories segment dominated the global histopathology services market and accounted for the largest revenue share of 71.74% in 2021.
The histopathology services market majorly consists of the players such Sonic Healthcare Limited, Laboratory Corporation of America Holdings, Acculabs Diagnostics UK Ltd, TPL Path Labs, UNILABS, Cureline Global Translational CRO, Targos, Cellular Pathology Services, Experimental Pathology Laboratories Inc (EPL), and CHARLES RIVER LABORATORIES, INC. among others.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Histopathology Services Market – By Type of Examination
1.3.2 Global Histopathology Services Market – By End User
1.3.3 Global Histopathology Services Market – By Geography
2. Histopathology Services Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Histopathology Services Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa (MEA) – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.3 Expert Opinions
5. Histopathology Services Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Demand for Biologics
5.1.2 Increasing Prevalence of Chronic Diseases
5.2 Market Restraints
5.2.1 Limitations Associated with Histopathology and Immunohistochemistry
5.3 Market Opportunities
5.3.1 Potential Growth Opportunities in Emerging Economies
5.4 Future Trends
5.4.1 Strategic Alliances Among Market Players
5.5 Impact Analysis
6. Histopathology Services Market – Global Analysis
6.1 Global Histopathology Services Market Revenue Forecast and Analysis
6.2 Global Histopathology Services Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Histopathology Services Market Analysis – By Type of Examination
7.1 Overview
7.2 Histopathology Services Market Revenue Share, by Type of Examination (2021 and 2028)
7.3 Surgical Specimen
7.3.1 Overview
7.3.2 Surgical Specimen: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Breast Biopsy
7.4.1 Overview
7.4.2 Breast Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Lung Biopsy
7.5.1 Overview
7.5.2 Lung Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Renal Biopsy
7.6.1 Overview
7.6.2 Renal Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Gastrointestinal Biopsy
7.7.1 Overview
7.7.2 Gastrointestinal Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Pancreatic Biopsy
7.8.1 Overview
7.8.2 Pancreatic Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Skin Tissue Biopsy
7.9.1 Overview
7.9.2 Skin Tissue Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
7.10 Testicular Biopsy
7.10.1 Overview
7.10.2 Testicular Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
7.11 Others
7.11.1 Overview
7.11.2 Others: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
8. Histopathology Services Market Analysis – By End-User
8.1 Overview
8.2 Histopathology Services Market Share, by End-User, 2021 and 2028, (%)
8.3 Diagnostic Laboratories and Reference Laboratories
8.3.1 Overview
8.3.2 Diagnostic Laboratories and Reference Laboratories: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Research Institutes
8.4.1 Overview
8.4.2 Research Institutes: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
9. Histopathology Services Market – Geographic Analysis
9.1 North America: Histopathology Services Market
9.1.1 Overview
9.1.2 North America: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.3 North America: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.1.4 North America: Histopathology Services Market, by End-User, 2019-2028 (USD Million)
9.1.5 North America: Histopathology Services Market, by Country, 2021 & 2028 (%)
9.1.6 US: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.6.1 US: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.6.2 US: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.1.6.3 US: Histopathology Services, Market, by End-User, 2019-2028 (USD Million)
9.1.7 Canada: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.7.1 Canada: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.7.2 Canada: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.1.7.3 Canada: Histopathology Services Market, by End-User, 2019-2028 (USD Million)
9.1.8 Mexico: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.8.1 Mexico: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.8.2 Mexico: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.1.8.3 Mexico: Histopathology Services, Market, by End-User, 2019-2028 (USD Million)
9.2 Europe: Histopathology Services Market
9.2.1 Overview
9.2.2 Europe: Histopathology Services Market - Revenue and Forecast to 2028 (USD Million)
9.2.3 Europe: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.2.4 Europe: Histopathology Services Market, by End-User, 2019-2028 (USD Million)
9.2.5 Europe: Histopathology Services Market, by Country, 2021 & 2028 (%)
9.2.6 Germany: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.2.6.1 Germany: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.2.6.2 Germany: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.2.6.3 Germany: Histopathology Services Market, by End-User, 2019-2028 (USD Million)
9.2.7 UK: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.2.7.1 UK: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.2.7.2 UK: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.2.7.3 UK: Histopathology Services Market, by End-User, 2019-2028 (USD Million)
9.2.8 France: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.2.8.1 France: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.2.8.2 France: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.2.8.3 France: Histopathology Services Market, by End-User, 2019-2028 (USD Million)
9.2.9 Spain: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.2.9.1 Spain: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.2.9.2 Spain: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.2.9.3 Spain: Histopathology Services Market, by End-User, 2019-2028 (USD Million)
9.2.10 Italy: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.2.10.1 Italy: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.2.10.2 Italy: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.2.10.3 Italy: Histopathology Services Market, by End-User, 2019-2028 (USD Million)
9.2.11 Rest of Europe: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.2.11.1 Rest of Europe: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.2.11.2 Rest of Europe: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.2.11.3 Rest of Europe: Histopathology Services Market, by End-User, 2019-2028 (USD Million)
9.3 Asia-Pacific: Histopathology Services Market
9.3.1 Overview
9.3.2 Asia-Pacific: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.3.5 Asia-Pacific: Histopathology Services Market, by Country, 2021 & 2028 (%)
9.3.6 China: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.3.6.1 China: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.3.6.2 China: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.3.6.3 China: Histopathology Services Market, by End-User, 2019-2028 (USD Million)
9.3.7 Japan: Histopathology Services Market - Revenue and Forecast to 2028 (USD Million)
9.3.7.1 Japan: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.3.7.2 Japan: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.3.7.3 Japan: Histopathology Services Market, by End-User, 2019-2028 (USD Million)
9.3.8 India: Histopathology Services Market - Revenue and Forecast to 2028 (USD Million)
9.3.8.1 India: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.3.8.2 India: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.3.8.3 India: Histopathology Services Market, by End-User, 2019-2028 (USD Million)
9.3.9 South Korea: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.3.9.1 South Korea: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.3.9.2 South Korea: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.3.9.3 South Korea: Histopathology Services Market, by End-User, 2019-2028 (USD Million)
9.3.10 Australia: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.3.10.1 Australia: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.3.10.2 Australia: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.3.10.3 Australia: Histopathology Services Market, by End-User, 2019-2028 (USD Million)
9.3.11 Rest of Asia Pacific: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.3.11.1 Rest of Asia Pacific: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.3.11.2 Rest of Asia Pacific: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.3.11.3 Rest of Asia Pacific: Histopathology Services Market, by End-User, 2019-2028 (USD Million)
9.4 Middle East and Africa: Histopathology Services Market
9.4.1 Overview
9.4.2 Middle East and Africa: Histopathology Services Market- Revenue and Forecast to 2028 (USD Million)
9.4.5 Middle East and Africa: Histopathology Services Market, by Country, 2021 & 2028 (%)
9.4.6 Saudi Arabia: Histopathology Services Market– Revenue and Forecast to 2028 (USD Million)
9.4.6.1 Saudi Arabia: Histopathology Services Market– Revenue and Forecast to 2028 (USD Million)
9.4.6.2 Saudi Arabia: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.4.6.3 Saudi Arabia: Histopathology Services, Market, by End-User, 2019-2028 (USD Million)
9.4.7 UAE: Histopathology Services Market– Revenue and Forecast to 2028 (USD Million)
9.4.7.1 UAE: Histopathology Services Market– Revenue and Forecast to 2028 (USD Million)
9.4.7.2 UAE: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.4.7.3 UAE: Histopathology Services, Market, by End-User, 2019-2028 (USD Million)
9.4.8 South Africa: Histopathology Services Market– Revenue and Forecast to 2028 (USD Million)
9.4.8.1 South Africa: Histopathology Services Market– Revenue and Forecast to 2028 (USD Million)
9.4.8.2 South Africa: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.4.8.3 South Africa: Histopathology Services Market, by End-User, 2019-2028 (USD Million)
9.4.9 Rest of Middle East and Africa: Histopathology Services Market– Revenue and Forecast to 2028 (USD Million)
9.4.9.1 Rest of Middle East and Africa: Histopathology Services Market– Revenue and Forecast to 2028 (USD Million)
9.4.9.2 Rest of Middle East and Africa: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.4.9.3 Rest of Middle East and Africa: Histopathology Services Market, by End-User, 2019-2028 (USD Million)
9.5 South and Central America: Histopathology Services Market
9.5.1 Overview
9.5.2 South and Central America: Histopathology Services Market - Revenue and Forecast to 2028 (US$ Million)
9.5.3 South and Central America: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.5.4 South and Central America: Histopathology Services Market, by End-User, 2019-2028 (USD Million)
9.5.5 South and Central America: Histopathology Services Market, by Country, 2021 & 2028 (%)
9.5.6 Brazil: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.5.6.1 Brazil: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.5.6.2 Brazil: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.5.6.2.1 Brazil: Histopathology Services Market, by End-User, 2019-2028 (USD Million)
9.5.7 Argentina: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.5.7.1 Argentina: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.5.7.2 Argentina: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.5.7.3 Argentina: Histopathology Services Market, by End-User, 2019-2028 (USD Million)
9.5.8 Rest of South and Central America: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.5.8.1 Rest of South and Central America: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.5.8.2 Rest of South and Central America: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.5.8.3 Rest of South and Central America: Histopathology Services Market, by End-User, 2019-2028 (USD Million)
10. Impact of COVID-19 Pandemic on Global Histopathology Services Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment Of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Developments by Key Market Players
11.3.1 Overview
12. Company Profiles
12.1 Sonic Healthcare Limited
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Laboratory Corporation of America Holdings
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Acculabs Diagnostics UK Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 TPL Path Labs
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 UNILABS
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Cureline Global Translational CRO
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Targos
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Cellular Pathology Services
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Financial Overview
12.8.4 SWOT Analysis
12.8.5 Key Developments
12.9 Experimental Pathology Laboratories Inc (EPL)
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 CHARLES RIVER LABORATORIES, INC.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Histopathology Services Market, by Type of Examination– Revenue and Forecast to 2028 (USD Million)
Table 2. North America Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 3. Estimated Number of New Cancer Cases and Deaths, US, 2020
Table 4. US Histopathology Services Market, by Type of Examination– Revenue and Forecast to 2028 (USD Million)
Table 5. US Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 6. Canada Histopathology Services Market, by Type of Examination– Revenue and Forecast to 2028 (USD Million)
Table 7. Canada Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 8. Mexico Incidence, Mortality and Prevalence by Cancer Site in 2018
Table 9. Mexico Histopathology Services Market, by Type of Examination– Revenue and Forecast to 2028 (USD Million)
Table 10. Mexico Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 11. Europe Histopathology Services Market, by Type of Examination– Revenue and Forecast to 2028 (USD Million)
Table 12. Europe Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 13. Incidence, Mortality and Prevalence by cancer site, 2018, Germany
Table 14. Germany Histopathology Services Market, by Type of Examination– Revenue and Forecast to 2028 (USD Million)
Table 15. Germany Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 16. UK Histopathology Services Market, by Type of Examination– Revenue and Forecast to 2028 (USD Million)
Table 17. UK Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 18. Incidence, Mortality and Prevalence By Cancer Site, 2018, France
Table 19. France Histopathology Services Market, by Type of Examination– Revenue and Forecast to 2028 (USD Million)
Table 20. France Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 21. Spain Histopathology Services Market, by Type of Examination– Revenue and Forecast to 2028 (USD Million)
Table 22. Spain Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 23. Incidence, Mortality and Prevalence by cancer site, 2018, Italy
Table 24. Italy Histopathology Services Market, by Type of Examination– Revenue and Forecast to 2028 (USD Million)
Table 25. Italy Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 26. Rest of Europe Histopathology Services Market, by Type of Examination– Revenue and Forecast to 2028 (USD Million)
Table 27. Rest of Europe Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 30. China Histopathology Services Market, by Type of Examination – Revenue and Forecast to 2028 (USD Million)
Table 31. China Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 32. Japan Histopathology Services Market, by Type of Examination – Revenue and Forecast to 2028 (USD Million)
Table 33. Japan Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 34. India Histopathology Services Market, by Type of Examination – Revenue and Forecast to 2028 (USD Million)
Table 35. India Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 36. South Korea Histopathology Services Market, by Type of Examination – Revenue and Forecast to 2028 (USD Million)
Table 37. South Korea Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 38. Incidence, Mortality and Prevalence by cancer site, Australia, 2018
Table 39. Australia Histopathology Services Market, by Type of Examination – Revenue and Forecast to 2028 (USD Million)
Table 40. Australia Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 41. Rest of Asia Pacific Histopathology Services Market, by Type of Examination – Revenue and Forecast to 2028 (USD Million)
Table 42. Rest of Asia Pacific Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 45. Saudi Arabia Histopathology Services Market, by Type of Examination – Revenue and Forecast to 2028 (USD Million)
Table 46. Saudi Arabia Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 47. UAE Histopathology Services Market, by Type of Examination – Revenue and Forecast to 2028 (USD Million)
Table 48. UAE Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 49. South Africa Histopathology Services Market, by Type of Examination – Revenue and Forecast to 2028 (USD Million)
Table 50. South Africa Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 51. Rest of Middle East and Africa Histopathology Services Market, by Type of Examination – Revenue and Forecast to 2028 (USD Million)
Table 52. Rest of Middle East and Africa Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 53. South and Central America Histopathology Services Market, by Type of Examination– Revenue and Forecast to 2028 (USD Million)
Table 54. South and Central America Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 55. Brazil Histopathology Services Market, by Type of Examination– Revenue and Forecast to 2028 (USD Million)
Table 56. Brazil Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 57. Argentina Histopathology Services Market, by Type of Examination– Revenue and Forecast to 2028 (USD Million)
Table 58. Argentina Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 59. Rest of South and Central America Histopathology Services Market, by Type of Examination– Revenue and Forecast to 2028 (USD Million)
Table 60. Rest of South and Central America Histopathology Services Market, by End-User – Revenue and Forecast to 2028 (USD Million)
Table 61. Developments Done by Key Players
Table 62. Glossary of Terms, Histopathology Services Market
LIST OF FIGURES
Figure 1. Histopathology Services Market Segmentation
Figure 2. Histopathology Services Market Segmentation, By Region
Figure 3. Histopathology Services Market Overview
Figure 4. Surgical Specimen Segment Held Largest Share of Histopathology Services Market
Figure 5. APAC to Show Significant Growth During Forecast Period
Figure 6. Histopathology Services Market, by Geography (US$ Million)
Figure 7. Global Histopathology Services Market – Leading Country Markets (US$ Million)
Figure 8. Global Histopathology Services Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Histopathology Services Market Impact Analysis of Drivers and Restraints
Figure 15. Global Histopathology Services Market – Revenue Forecast and Analysis – 2020- 2028
Figure 16. Global Histopathology Services Market – By Geography Forecast and Analysis – 2021- 2028
Figure 17. Market Positioning of Key Players in Global Histopathology Services Market
Figure 18. Histopathology Services Market Revenue Share, by Type of Examination (2021 and 2028)
Figure 19. Surgical Specimen: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Breast Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Lung Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Renal Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Gastrointestinal Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Pancreatic Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Skin Tissue Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Testicular Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Others: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Histopathology Services Market Share, by End-User, 2021 and 2028 (%)
Figure 29. Diagnostic Laboratories and Reference Laboratories: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Research Institutes: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Others: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. North America: Market, by Key Country – Revenue (2021) (USD Million)
Figure 33. North America Histopathology Services Market Revenue and Forecast to 2028 (USD Million)
Figure 34. North America: Histopathology Services Market, by Country, 2021 & 2028 (%)
Figure 35. US: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Canada: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Mexico: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 38. Europe: Histopathology Services Market, by Key Country – Revenue (2021) (USD Million)
Figure 39. Europe Histopathology Services Market Revenue and Forecast to 2028 (USD Million)
Figure 40. Europe: Histopathology Services Market, by Country, 2021 & 2028 (%)
Figure 41. Germany: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 42. UK: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 43. France: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 44. Spain: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 45. Italy: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 46. Rest of Europe: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 47. Asia-Pacific: Histopathology Services Market, by Key Country – Revenue (2021) (USD Millions)
Figure 48. Asia-Pacific Histopathology Services Market Revenue and Forecast to 2028 (USD Million)
Figure 49. Asia-Pacific: Histopathology Services Market, by Country, 2021 & 2028 (%)
Figure 50. China Histopathology Services Market Revenue and Forecast to 2028 (USD Million)
Figure 51. Japan Histopathology Services Market Revenue and Forecast to 2028 (USD Million)
Figure 52. India Histopathology Services Market Revenue and Forecast to 2028 (USD Million)
Figure 53. South Korea Histopathology Services Market Revenue and Forecast to 2028 (USD Million)
Figure 54. Australia Histopathology Services Market Revenue and Forecast to 2028 (USD Million)
Figure 55. Rest of Asia Pacific Histopathology Services Market Revenue and Forecast to 2028 (USD Million)
Figure 56. Middle East and Africa: Histopathology Services Market, by Key Country – Revenue (2021) (USD Million)
Figure 57. Middle East and Africa Histopathology Services Market Revenue and Forecast to 2028 (USD Million)
Figure 58. Middle East and Africa: Histopathology Services Market, by Country, 2021 & 2028 (%)
Figure 59. Saudi Arabia: Histopathology Services Market– Revenue and Forecast to 2028 (USD Million)
Figure 60. UAE: Histopathology Services Market– Revenue and Forecast to 2028 (USD Million)
Figure 61. South Africa: Histopathology Services Market– Revenue and Forecast to 2028 (USD Million)
Figure 62. Rest of Middle East and Africa: Histopathology Services Market– Revenue and Forecast to 2028 (USD Million)
Figure 63. South and Central America: Histopathology Services Market, by Key Country – Revenue (2021) (USD Million)
Figure 64. South and Central America Histopathology Services Market Revenue and Forecast to 2028 (USD Million)
Figure 65. South and Central America: Histopathology Services Market, by Country, 2021 & 2028 (%)
Figure 66. Brazil: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 67. Argentina: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 68. Rest of South and Central America: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 69. Impact of COVID-19 Pandemic in North American Country Markets
Figure 70. Impact of COVID-19 Pandemic in European Country Markets
Figure 71. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
Figure 72. Impact Of COVID-19 Pandemic in Rest of the World Countries Market
Figure 73. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Histopathology Services Market
- Sonic Healthcare Limited
- Laboratory Corporation of America Holdings
- Acculabs Diagnostics UK Ltd
- TPL Path Labs
- UNILABS
- Cureline Global Translational CRO
- Targos
- Cellular Pathology Services,
- Experimental Pathology Laboratories Inc (EPL)
- CHARLES RIVER LABORATORIES, INC.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Histopathology Services Market
Aug 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Aug 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Aug 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Aug 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Aug 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Aug 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Aug 2021